Is Access Problem Preventing Generic Drug Makers’ Progress?
The Washington Post: Generic-Drug Makers' Complaints Over Brand-Name Access Prompt Investigations
Some drugmakers assert they are unable to create cheaper generic versions of drugs because their rivals are exploiting a legal loophole. It all comes down to process: To get a generic drug approved for sale, a company has to test a sample of the brand-name version and show regulators that the generic version is essentially identical and as effective (ElBoghdady, 5/22).